TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Sep 16, 2026 · 4:00 PM EDT

TFA Therapeutics (RAJAF) Profit After Tax (2020 - 2023)

TFA Therapeutics (RAJAF) posted Profit After Tax of $671286.0 for Q4 2023, up 150.32% on a QoQ basis from -$1.3 million in Q4 2022, and up 150.32% year-over-year from $268171.2 in Q4 2022.

Analysis

TFA Therapeutics (RAJAF) Profit After Tax (2020 - 2023) Analysis & Trends

TFA Therapeutics has reported Profit After Tax for 3 years, with the latest figure at $671286.0 in Q4 2023.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Colgate Palmolive 69.71 Bn 68.67 Bn 3.30 Bn 719.00 Mn
2 Kenvue 34.22 Bn 33.11 Bn 2.30 Bn 456.00 Mn
3 Kimberly Clark 32.55 Bn 31.72 Bn 1.60 Bn 410.00 Mn
4 Bath & Body Works 3.52 Bn 2.73 Bn 692.00 Mn 118.00 Mn
5 Prestige Consumer Healthcare 2.52 Bn 2.46 Bn - -
6 Perrigo 1.88 Bn 1.49 Bn 313.90 Mn 88.50 Mn
7 Edgewell Personal Care 1.25 Bn 854.93 Mn 242.50 Mn 13.70 Mn
8 Herbalife 1.25 Bn 883.17 Mn 1.03 Bn -26.50 Mn
9 TFA Therapeutics 1.02 Bn 1.02 Bn - -
10 Honest Company 611.15 Mn 505.26 Mn 40.36 Mn 10.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 671,286.00
Dec 31, 2022 -1.33 Mn
Dec 31, 2020 -13,476.00